Publications by authors named "Susanne Aagaard"
Article Synopsis
- The World Health Organization emphasizes that palliative care should be accessible to everyone with life-threatening diseases, yet current global practices primarily focus on cancer patients.
- A task force in Denmark created a national position statement aimed at implementing palliative care for severe heart disease, highlighting the need for tools to identify when and how to provide this care.
- The position statement offers practical guidance for managing symptoms across different stages of advanced heart disease, underscores the importance of communication, and advocates for multidisciplinary collaboration in care delivery.
Advance care planning and place of death, hospitalisation and actual place of death in lung, heart and cancer disease: a randomised controlled trial.
BMJ Support Palliat Care
December 2020
Objectives: Advance care planning (ACP) can be a way to meet patients' end-of-life preferences and enhance awareness of end-of-life care. Thereby it may affect actual place of death (APOD) and decrease the rate of hospitalisations. The aim was to investigate if ACP among terminally ill patients with lung, heart and cancer diseases effects fulfilment of preferred place of death (PPOD), amount of time spent in hospital and APOD.
View Article and Find Full Text PDFBackground: Advance care planning (ACP) has been suggested to improve the quality of life (QoL) and mental wellbeing in severely ill patients and their relatives.
Aim: To investigate the effects of ACP among patients with lung, heart and cancer diseases with an estimated life-span of up to 12 months.
Methods: Patients and relatives were randomised into two groups: one receiving usual care and one receiving ACP and usual care.
Objectives: The dual aim of this study is, first, to describe preferred place of care (PPOC) and preferred place of death (PPOD) in terminally ill patients with lung and heart diseases compared with cancer patients and second, to describe differences in level of anxiety among patients with these diagnoses.
Background: Previous research on end-of-life preferences focuses on cancer patients, most of whom identify home as their PPOC and PPOD. These preferences may, however, not mirror those of patients suffering from nonmalignant fatal diseases.
Tissue factor pathway inhibitor (TFPI) acts by complexing with tissue factor and factors VIIa and Xa to retard the extrinsic pathway of the coagulative process. The present study was designed to assess the antithrombotic properties of topically applied TFPI in a model of rabbit arterial thrombosis. A standardised, thrombogenic end-to-end anastomosis was made on the central ear artery.
View Article and Find Full Text PDF